# FDA Inspection 1221607 - Peter Tenke, M.D., PhD, Principal Investigator - October 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/peter-tenke-md-phd-principal-investigator/4da1e537-bbfc-415f-8976-4fd485c5a063
Source feed: FDA_Inspections

> FDA Inspection 1221607 for Peter Tenke, M.D., PhD, Principal Investigator on October 19, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1221607
- Company Name: Peter Tenke, M.D., PhD, Principal Investigator
- Inspection Date: 2023-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1052466 - 2018-04-13](https://www.keypedia.com/records/fda_inspections/peter-tenke-md-phd-principal-investigator/8251d68a-36a3-475a-8347-33b6fe088458)

Company: https://www.keypedia.com/companies/peter-tenke-md-phd-principal-investigator/b27739a1-8433-4c9a-8191-7913e9edad75

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c